To determine the risk factors associated with toxic-shock syndrome (TSS) in menstruating women, we conducted a retrospective telephone study of 52 cases and 52 age-matched and sex-matched controls. Fifty-two cases and 44 controls used tampons (P < 0.02). Moreover, in case-control pairs in which both women used tampons, cases were more likely than controls to use tampons throughout menstruation (42 of 44 vs. 34 of 44, respectively; P < 0.05). There were no significant differences in brand of tampon used, degree of absorbency specified on label, frequency of tampon change, type of contraceptive used, frequency of sexual intercourse, or sexual intercourse during menstruation. Fourteen of 44 cases had one or more definite or probable recurrences during a subsequent menstrual period. In a separate study, Staphylococcus aureus was isolated from 62 of 64 women with TSS and from seven of 71 vaginal cultures obtained from healthy controls (P < 0.001).
This article has been cited by other articles:
Parsonnet, J., Goering, R. V., Hansmann, M. A., Jones, M. B., Ohtagaki, K., Davis, C. C., Totsuka, K.
(2008). Prevalence of Toxic Shock Syndrome Toxin 1 (TSST-1)-Producing Strains of Staphylococcus aureus and Antibody to TSST-1 among Healthy Japanese Women. J. Clin. Microbiol.
46: 2731-2738
[Abstract][Full Text]
Schlievert, P. M., Case, L. C., Strandberg, K. L., Tripp, T. J., Lin, Y.-C., Peterson, M. L.
(2007). Vaginal Staphylococcus aureus Superantigen Profile Shift from 1980 and 1981 to 2003, 2004, and 2005. J. Clin. Microbiol.
45: 2704-2707
[Abstract][Full Text]
Young, A. E, Thornton, K. L
(2007). Toxic shock syndrome in burns: diagnosis and management. EDUCATION AND PRACTICE
92: ep97-ep100
[Full Text]
Byer, R. L., Bachur, R. G.
(2006). Clinical Deterioration Among Patients With Fever and Erythroderma. Pediatrics
118: 2450-2460
[Abstract][Full Text]
Siegel, M. D., Kimmel, R.
(2006). A 48-Year-Old Woman With Pneumonia, Shock, and a Rash. Chest
129: 1724-1727
[Full Text]
Hill, D. R., Brunner, M. E., Schmitz, D. C., Davis, C. C., Flood, J. A., Schlievert, P. M., Wang-Weigand, S. Z., Osborn, T. W.
(2005). In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J. Appl. Physiol.
99: 1582-1591
[Abstract][Full Text]
Parsonnet, J., Hansmann, M. A., Delaney, M. L., Modern, P. A., DuBois, A. M., Wieland-Alter, W., Wissemann, K. W., Wild, J. E., Jones, M. B., Seymour, J. L., Onderdonk, A. B.
(2005). Prevalence of Toxic Shock Syndrome Toxin 1-Producing Staphylococcus aureus and the Presence of Antibodies to This Superantigen in Menstruating Women. J. Clin. Microbiol.
43: 4628-4634
[Abstract][Full Text]
Peterson, M. L., Ault, K., Kremer, M. J., Klingelhutz, A. J., Davis, C. C., Squier, C. A., Schlievert, P. M.
(2005). The Innate Immune System Is Activated by Stimulation of Vaginal Epithelial Cells with Staphylococcus aureus and Toxic Shock Syndrome Toxin 1. Infect. Immun.
73: 2164-2174
[Abstract][Full Text]
Tierno, P. M. Jr., Schlievert, P. M., Tripp, T. J., Peterson, M. L.
(2005). Reemergence of Staphylococcal Toxic Shock Syndrome in the United States since 2000. J. Clin. Microbiol.
43: 2032-2033
[Full Text]
Schlievert, P. M., Tripp, T. J., Peterson, M. L.
(2004). Reemergence of Staphylococcal Toxic Shock Syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 Surveillance Period. J. Clin. Microbiol.
42: 2875-2876
[Full Text]
Ross, R. A., Onderdonk, A. B.
(2000). Production of Toxic Shock Syndrome Toxin 1 by Staphylococcus aureus Requires Both Oxygen and Carbon Dioxide. Infect. Immun.
68: 5205-5209
[Abstract][Full Text]
Yarwood, J. M., Schlievert, P. M.
(2000). Oxygen and Carbon Dioxide Regulation of Toxic Shock Syndrome Toxin 1 Production by Staphylococcus aureus MN8. J. Clin. Microbiol.
38: 1797-1803
[Abstract][Full Text]
Dinges, M. M., Orwin, P. M., Schlievert, P. M.
(2000). Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev.
13: 16-34
[Abstract][Full Text]
Ladhani, S., Joannou, C. L., Lochrie, D. P., Evans, R. W., Poston, S. M.
(1999). Clinical, Microbial, and Biochemical Aspects of the Exfoliative Toxins Causing Staphylococcal Scalded-Skin Syndrome. Clin. Microbiol. Rev.
12: 224-242
[Abstract][Full Text]
Younis, R. T., Lazar, R. H.
(1996). Delayed Toxic Shock Syndrome After Functional Endonasal Sinus Surgery. Arch Otolaryngol Head Neck Surg
122: 83-85
[Abstract]
Krause, R. M.
(1992). The Origin of Plagues: Old and New. Science
257: 1073-1078
[Abstract]
Jacobson, J. A., Stevens, M. H., Kasworm, E. M.
(1988). Evaluation of Single-Dose Cefazolin Prophylaxis for Toxic Shock Syndrome. Arch Otolaryngol Head Neck Surg
114: 326-327
[Abstract]
Glass, R.
(1986). New prospects for epidemiologic investigations. Science
234: 951-955
[Abstract]
Hull, H. F., Mann, J. M., Sands, C. J., Gregg, S. H., Kaufman, P. W.
(1983). Toxic Shock Syndrome Related to Nasal Packing. Arch Otolaryngol Head Neck Surg
109: 624-626
[Abstract]
Toback, J., Fayerman, J. W.
(1983). Toxic Shock Syndrome Following Septorhinoplasty: Implications for the Head and Neck Surgeon. Arch Otolaryngol Head Neck Surg
109: 627-629
[Abstract]
Morrison, V. A., Oldfield, E. C. III
(1983). Postoperative Toxic Shock Syndrome. Arch Surg
118: 791-794
[Abstract]
Schutzer, S., Fischetti, V., Zabriskie, J.
(1983). Toxic shock syndrome and lysogeny in Staphylococcus aureus. Science
220: 316-318
[Abstract]
Dmytryshyn, J. R., Gribble, M. J., Kassen, B. O.
(1983). Chemical Face Peel Complicated by Toxic Shock Syndrome: A Case Report. Arch Otolaryngol Head Neck Surg
109: 170-171
[Abstract]